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Abstract 
Co-activation and cross-talk of different apoptotic pathways have been described in several 
systems however, the differential contributions of the different executors have not been well 
characterized. Here we report the co-translocation to the nucleus of caspase-12 and AIF in 
response to two endoplasmic reticulum (ER) stresses: protein misfolding and disruption of 
calcium homeostasis. As seen by treatment with pan-caspase inhibitor and calpain inhibitors, 
apoptosis is not mediated by executor caspases but by calpains. By reduction of AIF or 
caspase-12 expression we unraveled that AIF primarily controls apoptosis caused by changes 
in calcium homeostasis while caspase-12 has a main role in programmed cell death induced 
by protein misfolding. Nevertheless, the two apoptotic factors appear to reinforce each other 
during the apoptotic process, confirming that while the first response primarily involves one 
organelle, mitochondria and ER can influence each other in the apoptotic event.   
 
 
Keywords: AIF; caspase-12; thapsigargin; tunicamycin; endoplasmic reticulum. 
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Introduction 
 
Apoptosis can be activated through extrinsic or intrinsic pathways. Extrinsic pathways 
preferentially activate caspases that are cysteine proteases mediating apoptotic death in a 
variety of cellular systems. There are several examples of intrinsic pathways mediated by the 
mitochondria and, in response to apoptotic stimuli, several proteins are released from the 
intermembrane space of the organelle into the cytoplasm. Among them is cytochrome c that 
is involved in formation of the apoptosome, which leads to the activation of executor 
caspases 1. Accumulating evidences suggest that other organelles, including the endoplasmic 
reticulum (ER) are also major points of integration of pro-apoptotic signaling. Each organelle 
possesses sensors that detect specific alterations, locally activates signal transduction 
pathways and emits signals that ensure inter-organellar cross-talk. The ER senses local stress 
through chaperones, Ca2+-binding proteins and Ca2+ release channels, which can transmit ER 
Ca2+ responses to mitochondria. 
Although caspases are frequently activated during cell death, in some cases caspase 
inhibition does not prevent apoptosis. A second family of proteases is the calpain family of 
calcium activated cysteine proteases 2. Like caspases, they are synthesized as inactive pro-
enzymes and can be autoprocessed to become active. Calpains are sensitive to increase of 
intracellular calcium levels for activation. Two ubiquitously expressed calpains are the 
isozymes µ-calpain and m-calpain, activated in vitro by micromolar and millimolar calcium 
concentrations respectively 3. Calpains do not directly cause chromatin condensation but they 
are proteases that activate apoptotic factors. 
Caspase-12 is a murine caspase belonging to the inflammatory caspase subgroup 
including caspase-1, -4, -5 and -11 4. Interestingly, caspase-12 has been linked to neuronal 
degeneration in neurotoxicity caused by amyloid-β protein 5, by prion protein 6 and in animal 
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models of ALS 7. Caspase-12 is activated by m-calpain by elevated intracellular calcium in 
the presence of the pan-caspase inhibitor zVAD.fmk 8. The cleaved active form of caspase-12 
participates to the apoptotic event by translocation to the nucleus 9 or possibly through other 
caspases 6, 7. Caspase-12 had been localized on the cytoplasmic side of the ER 5. The 
observation that caspase-12 processing occurs during ER stress apoptosis has favored the 
idea that caspase-12 may be the initiator caspase during this process. However, absence of 
caspase-12 causes only a 12% reduction of ER stress apoptosis 5. This evidence suggests that 
multiple mechanisms are operating during the apoptotic process.  
Apoptosis-inducing factor (AIF) is a flavoprotein localized in the mitochondrial 
intermembrane space. It can exit the mitochondrion and directly translocate to the nucleus to 
execute DNA fragmentation that culminates in cell death 10. Cleavage and release of AIF 
from mitochondria is regulated under some conditions by µ-calpain 11, 12. AIF is able to 
mediate caspase-independent cell death because inhibition of caspase activation or activity 
does not always abolish AIF proapoptotic function 13. It appears that there are several 
different mechanisms to release AIF from motochondria, either caspase dependent or 
independent 14. Furthermore, the release of AIF from mitochondrion can occur independently 
from that of cytochrome c 15. While AIF is much larger than cytochrome c, in several 
neuronal injury systems translocation of AIF to the nucleus was observed prior to the 
mitochondrial release of cytochrome c 15. Finally, AIF activity can synergize and be 
enhanced by other factors like cyclophilin A 16.  
In many pathological conditions apoptosis is activated through multiple pathways 
involving mitochondria and endoplasmic reticulum 8, 17-19. The interdependence of multiple 
pathways is however not completely understood, and above all implication of executor 
caspases is still unclear. It is therefore very important to unravel interactions among different 
effectors of apoptosis that may be required to efficiently activate the apoptotic program. This 
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question is strictly related to development of therapeutic approaches to block apoptosis in 
diseases.  
Our study was aimed at defining cross-talks between mitochondrial and ER localized 
apoptotic factors in different ER stress conditions. We show that caspase-12 and AIF 
concomitantly re-localize to the nucleus as a consequence of ER stress caused by 
tunicamycin treatment or by disruption of calcium homeostasis by thapsigargin treatment. 
Conversely, oxidative stress and Mn(II) caused activation of only one of the two factors. As 
seen by treatment with pan-caspase inhibitor or calpain inhibitors, ER-stress induced 
apoptosis is not mediated by caspases but by calpains. Finally we defined that 
downregulation of AIF prevents cell demise when calcium homeostasis is disrupted by 
thapsigargin.  On the other hand, caspase-12 has a primary role in apoptosis caused by ER 
stress induced by protein misfolding.  
 
Materials and Methods 
Cell culture and treatments 
NIH3T3 fibroblasts were grown in DMEM supplemented with 10% FBS, penicillin 
(100U/ml) and streptomycin (50µg/ml) at 37°C in a 5% CO2 atmosphere. 
Apoptosis was induced by treatments with H2O2 (400µM) for 12h, MnCl2 (1µM) for 48h, 
thapsigargin (2µM; SIGMA, Milan, Italy) for 48h, tunicamycin (2µg/ml; SIGMA, Milan, 
Italy) for 48h. Cells were pre-treated with calpain inhibitor I (ALLN, N-Ac-L-L-norleucinal, 
25µM; Calbiochem, Darmstadt, Germany), calpain inhibitor II (ALLM, N-Ac-L-L-M-CHO, 
5µM; Calbiochem, Darmstadt, Germany), calpastatin (20µM; Calbiochem, Darmstadt, 
Germany), zVAD.fmk (N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, 50µM; 
SIGMA, Milan, Italy) for 30min before apoptosis induction. 
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Immunofluorescence 
Cells were fixed with 4% paraformaldehyde in PBS at room temperature for 30 min and 
washed in PBS. Samples were permeabilized with permeabilization buffer (0.1M NaCitrate, 
0.1% Triton X-100) for 2 min at 4°C and then blocked for 30 min in blocking buffer (3% 
BSA, 20% FBS, 0.5M Tris-HCl pH7.5). Apoptotic nuclei were detected by TdT-dUTP 
terminal nick-end labeling kit (TUNEL,fluorescein; Roche Diagnostics, Monza, Italy) 
according to the manufacturer’s protocols. Samples were then incubated overnight with 
primary antibodies for immunohistochemistry procedure. The primary antibodies used were: 
rabbit anti-AIF (1:100; SIGMA, Milan, Italy), rat anti caspase-12 (1:100; SIGMA, Milan, 
Italy), goat anti ERAB (1: 100; Santa Cruz biotechnology inc., Santa Cruz, CA, USA) and 
mouse anti cytochrome c (1:200; Promega Italia, Milan, Italy). After incubation for 45 
minutes with secondary Cy5 anti-rabbit (Jackson Immunoresearch, West Grove, PA, USA) 
and Alexa Fluor® 568 anti-rat and anti-rabbit antibodies (Molecular Probes, Eugene, OR, 
USA), slides were coverslipped with Vectashield (Vector laboratories, Burlingame, CA, 
USA) and photographed using either an Axioplan microscope (Zeiss) or a Leica Laser 
Confocal Microscope System.  
 
Protein fractionation and western blotting 
Cells were harvested in PBS and lysed in lysis buffer (50mM Tris-HCl pH 8.0, 1% NP-40, 
0.25% Na-deoxycholate, 150mM NaCl, 1mM EDTA, 1mM PMSF, aprotinin, leupeptin, 
pepstatin 1µg/ml each). When nucleus enriched lysates were prepared, cells were transferred 
to a 2ml Dounce homogenizer with 200µl of cold homogenizing buffer (20mM Hepes-KOH 
pH 7.5, 250mM sucrose, 10mM KCl, 1.5mM MgCl2, 1mM EDTA, 1mM EGTA, 1mM DTT, 
1mM PMSF, aprotinin, leupeptin, pepstatin 1µg/ml each) and incubated 30 min on ice. 
Plasma membrane was disrupted with 20 strokes and the nuclear fraction was isolated by 
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centrifugation at 900xg for 10 min at 4°C. The pellet was washed twice in cold homogenizing 
buffer and resuspended in lysis buffer. The purity of nuclear enriched lysates was controlled 
by western blot analysis using a specific nuclear marker (anti-acetyl-Histone H3 1:1000; 
SIGMA, Milan, Italy), the mitochondrial marker ATP synthase α subunit (C5, 1:1000, 
Molecular Probes, Eugene, OR, USA), and a cytosol marker (anti-actin, 1:1000, Santa Cruz 
Biotechnology, Santa Cruz, CA, USA).  
Equivalent amounts of protein extracts (60µg), as determined by the Bradford method (Bio-
Rad Italy, Segrate, Italy), were resolved using SDS-PAGE and western blot analysis was 
performed following standard procedures. The antibodies used were: rabbit anti-AIF (1:400; 
Oncogene Research Products, San Diego, CA, USA), rabbit anti-caspase-12 (1:1000; Cell 
Signaling Technology, Beverly, MA, USA), anti-caspase-3 active (1:500; SIGMA, Milan, 
Italy), anti caspase-9 (1: 500; SIGMA, Milan, Italy), anti-βtubulin (1:2500; SIGMA, Milan, 
Italy). 
 
shRNA constructs and clones 
Two sequences beginning with an AA dinucleotide were chosen in the caspase-12 mRNA: 
5’-AATGATGAGGATGATGGACCT and 5’- AACCCAAGATTCTCATCATGC and 
designed two hairpin RNAi template oligonucleotides: 
sense sequence I: 
5’GATCCCCAATGATGAGGATGATGGACCTTTCAAGAGAAGGTCCATCATCCTCA
TCATTTTTTTGGAAC;  
sense sequence II: 
5’GATCCCCAACCCAAGATTCTCATCATGCTTCAAGAGAGCATGATGAGAATCTT
GGGTTTTTTTGGAAC.  
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Control hairpin RNAi template oligonucleotide for sequence I was generated by 
mutagenizing 3 nucleotides (in bold) in the targeting sequence (underlined): 
Control caspase-12 sense sequence I: 
5’GATCCCCAATGCCGCGGATGATGGACCTTTCAAGAGAAGGTCCATCATCCGCG
GCATTTTTTTGGAAC;  
AIF hairpin siRNA template oligonucleotides were designed as previously reported 20. 
As control we mutated 3 nucleotides in the targeting sequence (shown in bold):  
5’GATCCCCTTCTTCTAGAAATGGCGTGTTCAAGAGACACGCCATTTCTAGAAGA
ATTTTTGGAAC. 
Sense and antisense oligonucleotides were annealed to form a hairpin siRNA template insert 
and cloned into the pSUPER vector (OligoEngine, Seattle, WA) using BglII/XhoI restriction 
sites. The insert was checked by sequencing. The template insert was then cloned into 
pRNAT-U6.1/neo vector using two external sites (EcoRI and KpnI). Stable transfection of 
shRNA vector was performed in NIH3T3 cells with the Polyfect transfection reagent 
(Qiagen, Milan, Italy) following the manufacturer’s protocol. Stable transfected clones were 
selected with G418 (1mg/ml). 
 
Calcium ion concentration measurement 
NIH3T3 cells were exposed to different stress stimuli and at different time points after 
treatment Fluo-4 AM (Molecular Probes, Eugene, OR, USA) was loaded into cells for 30 min 
at 37°C in calcium free medium. Cells were then washed in PBS and slides were 
coverslipped with Vectashield (Vector laboratories, Burlingame, CA, USA). Analysis was 
performed on 20 sequential layers of each cell at 488nm with a Leica Laser Confocal 
Microscope System. Images were then analyzed with the Leica confocal software (LCS). The 
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fluorescence average intensity (mean amplitude) of each area was measured. The average 
amplitude of 20 cells was reported as histogram. 
 
RT-PCR  
Total RNA from tunicamycin and thapsigargin treated cells was extracted by the TRIzol® 
methods (Gibco-BRL, Milan, Italy) at different time points. RT-PCR was performed in a 
two-step protocol using SuperScript™ II reverse transcriptase and Taq gold polymerase. The 
number of the cycles and the annealing temperature were adjusted depending on the gene 
amplified. Primers for RT-PCR analysis of CHOP/Gadd153 and GRP78/Bip expression 
were: GADDfw 5’TGCCTTTCTCCTTCGGGACAC and GADDrev 5’ 
GTGACCTCTGCTGGTTCTGGC; BIPfw 5’GATAATCAACCAACTGTTAC and BIPrev 
5’GTATCCTCTTCACCAGTTGG reverse. RT-PCR were normalized with GAPDH using as 
primers: 5’TGAAGGTCGGAGTCAACGGATTTG and 
5’CATGTGGGCCATGAGGTCCACCAC. 
 
Results 
Based on recent evidences reporting co-activation of multiple apoptotic pathways during cell 
demise, we investigated interaction between AIF and caspase-12 pathways in two different 
apoptotic conditions: disregulation of Ca2+ homeostasis and protein misfolding. We used 
thapsigargin that inhibits ER-associated Ca2+-ATPase and disrupts Ca2+ homeostasis 21. We 
found that NIH3T3 murine fibroblasts respond to thapsigargin stress undergoing apoptosis as 
detected by TUNEL staining (Figure 1F and P). Thapsigargin causes release of AIF from the 
mitochondria and translocation to the nucleus (Figure 1D). Nuclear localization was also 
confirmed by immunoblotting detecting AIF in nuclear fractions of thapsigargin stressed cells 
(57kD as previously reported 10, Figure 1Q). Thapsigargin treatment also activated caspase-
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12 that changed its subcellular localization from the ER to the nucleus (Figure 1E). Caspase-
12 is activated by cleavage (35kD and 42kD, as previously reported 9) and translocates to the 
nucleus (Figure 1F and Q). Tunicamycin is a specific inhibitor of N-glycosylation and 
inducer of ER stress 5. We similarly detected co-localization of AIF and caspase-12 inside the 
nuclei of cells undergoing apoptosis after tunicamycin treatment (Figure 1G-I and P and Q). 
Interestingly, we observed that thapsigargin causes a fast change in intracellular calcium 
within 6 hours after treatment (Figure 2A) while protein misfolding responses are activated 
only after 24 hours (Figure 2B). On the other hand, tunicamycin upregulates protein 
misfolding response factors within 12 hours (Figure 2B), while calcium concentration in the 
cells only slightly increased at the same time point (Figure 2A).  
We observed translocation of the two apoptotic factors in the same apoptotic cells as 
demonstrated by triple staining for TUNEL, AIF and caspase-12 (inserts in Figure 1D-I). 
Specificity of nuclear translocation of the two factors was demonstrated by confocal analysis 
of either a mitochondrial protein (cytochrome c in figure 2 C-K) or an ER marker (ERAB in 
figure 2L-T). Neither cytochrome c nor ERAB showed nuclear localization in these 
conditions. Co-localization of AIF and caspase-12 was not observed after H2O2 treatment that 
caused only translocation of AIF to the nucleus, as previously reported 14, but no activation of 
caspase-12 (Figure 1J-L, P and Q). On the other hand, Mn(II) induced mitochondria-
independent apoptosis via caspase-12 22 without release of AIF (Figure 1M-O, P and Q). 
While H2O2 activates caspase-3 and caspase-9, active fragments of these two executor 
caspases were not detectable after treatment with thapsigargin and tunicamycin (Figure 1R). 
These data showed for the first time co-localization of AIF and caspase-12 in the apoptotic 
nuclei. We also demonstrated that AIF and caspase-12 translocate to the nucleus in response 
to several apoptotic conditions, yet their co-localization appears to be a specific response to 
ER stress.  
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To confirm lack of involvement of executor caspases, shown by immunoblotting in figure 
1R, we exposed thapsigargin and tunicamycin treated cells to pan-caspase inhibitor 
zVAD.fmk. zVAD.fmk did not protect NIH3T3 cells from cell death, while it was effective 
on H2O2 treated cells (Figure 3A). Calpains have been previously reported to activate 
independently caspase-12 and AIF 8, 11. We therefore exposed thapsigargin treated cells to 
either calpain inhibitor I (ALLN) or calpain inhibitor II (ALLM) or a mixture of both. We 
calculated a reduction of 60% of thapsigargin induced apoptotic cells by treatment with 
ALLM, while ALLN appeared to be more efficient in blocking apoptosis (reduction to 10%). 
In tunicamycin treated cells ALLM showed a stronger inhibitory activity. The mixture of 
both ALLM and ALLN completely blocked apoptosis in both conditions (Figure 3A). We 
confirmed involvement of calpains by treating the cells with the calpastatin peptide, a specific 
inhibitor of calpains, able to block apoptosis induced by thapsigargina and tunicamycin 
(Figure 3A). We observed concomitant translocation of AIF and caspase-12 in cells 
undergoing apoptosis after treatment with caspase inhibitor but not in cells treated with the 
different calpain inhibitors (Figure 3C-Z). Western blot analysis confirmed that calpain 
inhibitors and calapstatin but not zVAD.fmk were efficiently blocking translocation of AIF 
and caspase-12 (Figure 3B).  
The observation that no thapsigargin or tunicamycin-treated cell showed single AIF or 
single caspase-12 relocalization to the nucleus suggested a direct cooperation of AIF and 
caspase-12 in activating apoptosis initiated by ER stress.  However, experiments presented so 
far did not allow to address whether apoptosis required the concomitant presence of AIF 
together with caspase-12 inside the nucleus. Otherwise the two pathways could act 
independently or could cooperate to activate cell death. To address this issue we generated 
NIH3T3 clones in which either expression of AIF or caspase-12 was repressed by RNA 
interference. Two different targeting sequences were chosen in the caspase-12 mRNA and 
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both shRNAs were able to efficiently knock-down caspase-12 expression (Figure 4K and 
data not shown). Figure 4 shows AIF and caspase-12 protein levels (tested by 
immunofluorescence and immunoblotting) in the interfered clones, clones 1 and 2 were 
chosen for AIF- experiments, clones 1 and 6 were used for caspase-12- experiments. 
Mutagenized targeting sequences were used (see Materials and Methods) as controls and 
these shRNAs did not affect expression of either protein (Figure 4B, G and K contr.).  
Absence of AIF completely abolished apoptosis induced by thapsigargin (Figure 5A, 
C-N and Table 1). Interestingly, we observed nuclear localization of caspase-12 in 24% of the 
AIF- cells treated with thapsigargin (Figure 5A and Table 1). These cells are not positive to 
TUNEL staining (Figure 5 F-H, arrow). When we treated AIF- cells with thapsigargin 
together with calpain inhibitors we blocked caspase-12 translocation to the nucleus (Figure 
5A-N). By counting the number of nuclei stained with caspase-12, we observed that ALLM 
alone could prevent caspase-12 activation similarly to the mixture of the ALLM and ALLN 
or to calpastatin peptide (Figure 5A and Table 1). As control, we treated AIF- cells with H2O2 
and all cells underwent apoptosis but caspase-12 was never found in the nucleus (Table 1). 
On the contrary, caspase-12 was always found inside the nucleus in AIF- apoptotic cells 
treated with Mn(II) or tunicamycin (Figure 5A, O-Z and Table 1). These data suggested that 
AIF mediates apoptosis caused by disruption of Ca2+ homeostasis, while it is dispensable 
when apoptosis is activated either by oxidative stress or by protein misfolding. The 
observation of caspase-12 inside the nucleus of TUNEL negative AIF- cells suggested that 
caspase-12 activation does not strictly correlate with apoptosis. In tunicamycin treated cells 
lack of AIF caused only partial reduction of apoptosis (20% versus 50%). All cells 
undergoing apoptosis showed caspase-12 localization to the nucleus (Figure 5A, R-T and 
Table 1). Interestingly, 3% of AIF- cells were stained by TUNEL even in the absence of 
apoptotic stimuli but caspase-12 was never detected in these nuclei (Figure 5A and Table 1). 
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This finding is not surprising, in fact absence of AIF was previously correlated with reduction 
of respiratory activity and cell death 23, 24. 
We then treated caspase-12- cells with thapsigargin and analyzed AIF subcellular 
localization. Downregulation of caspase-12 in NIH3T3 cells partially protected the cells from 
apoptosis in fact only 30% of the cells underwent programmed cell death (Figure 6A and 
Table 1). In all apoptotic cells we detected nuclear localization of AIF (Figure 6F-H, arrow). 
As expected caspase-12- cells underwent apoptosis when stressed with H2O2 and AIF always 
translocated to the nucleus (Table 1). Caspase-12- cells were otherwise resistant to Mn(II) 
stress and tunicamycin treatment (Figure 6A, O-Z and Table 1). Apoptosis caused by 
thapsigargin could be significantly reduced in caspase-12- cells by treatment with calpain 
inhibitors, blocking also AIF relocalization (Figure 6A-B, C-N and Table 1). Otherwise, 
zVAD.fmk did not protect caspase-12- cells from thapsigargin induced programmed cell 
death (Figure 6A and Table 1). Similar results were observed with both shRNAs targeting 
caspase-12 (data not shown). To confirm the effects that we observed in AIF- and caspase-12- 
cells were specific for the knock-down of the these factors, we performed similar experiments 
with a mutagenized shRNA (see Materials and Methods and figure 4). Cells expressing 
mutagenized shRNAs behaved like wild type cells (Figure 5A and 6A blue bars, and 5B and 
6B). All these data were confirmed by western blotting on nuclear enriched extracts purified 
from AIF- and Caspase-12- cells (Figures 5B and 6B). We also treated cells with thapsigargin 
and tunicamycin for prolonged time points (up to 72 hours) and we did not observe increased 
percentages of apoptotic cells in AIF- and caspase-12- cells (data not shown).  
 
Discussion 
In this paper we describe for the first time the cross-talk between two apoptotic pathways 
activated by ER stress when Ca2+ homeostasis and protein folding are disrupted. In these 
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conditions we observed translocation of AIF and caspase-12 to the nucleus. We also observed 
that in both apoptotic conditions interference with calpain activity blocks activation of the 
two factors. Calpains are calcium activated proteases and therefore intracellular Ca2+ 
concentration may play an important role in both apoptotic conditions. The mechanism 
through which thapsigargin alters calcium homeostasis is known 1, but tunicamycin treatment 
that affects N-glycosylation and protein folding may as well increase intracellular Ca2+. 
Protein misfolding and accumulation in the ER were previously reported to stimulate calcium 
influx 25. Furthermore, we also observed an increase in intracellular Ca2+ as a consequence of 
tunicamycin treatment. Initiation of these two pathways appears to be mediated by calpains, 
calcium dependent proteases, and not by caspases. In fact, we did not detect activated 
caspase-3 and caspase-9 and pancaspase inhibitor zVAD.fmk was unable to prevent 
apoptosis. Otherwise, calpain inhibitors were able to completely block cell death. Recently, 
no activation of AIF and caspase-12 was reported in a neuronal cell line exposed to 
tunicamycin 26. Those experiments were performed in a neuronal immortalized cell line by 
treating the cells with higher concentrations of the drug. This may activate different responses 
as also suggested by the very fast activation of GADD153 (6 hours) compared to the 
conditions applied in this study (activation of GADD153 can be detected only after 24 hours).  
The most interesting and novel finding reported in this paper is the differential 
contribution of ER released caspase-12 and mitochondrial released AIF in the two apoptotic 
conditions. By decreasing expression of either AIF or caspase-12 we defined that AIF is 
necessary for activation of apoptosis induced by thapsigargin while caspase-12 has a 
fundamental function when cell death is triggered by tunicamycin. Activated caspase-12 was 
anyway detected in the absence of AIF inside some nuclei that were not TUNEL positive. 
This observation implies that caspase-12 activation and translocation to the nucleus is not 
completely dependent on AIF, conversely it appears to be, at least partially, a direct response 
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to calpains. This is based on data showing that treatment with different calpain inhibitors is 
able to prevent caspase-12 activation in AIF- cells. Secondly, translocation to the nucleus of 
caspase-12 does not necessarily activate apoptosis. These data are in agreement with previous 
reports describing that caspase-12 may be dispensable for the execution of cell death after ER 
stress 5, 27. On the same line, we showed that downregulation of caspase-12 was partially 
beneficial to cells treated with thapsigargin. In the absence of caspase-12 we observed a strict 
correlation of cell demise with AIF translocation to the nucleus, and this is also dependent on 
calpain activity. These data unraveled a fundamental role of AIF in induction of cell death in 
conditions altering calcium homeostasis and the reduction of apoptosis in the absence of 
caspase-12 implies at least a partial contribution of this apoptotic factor.  
On the other hand, tunicamicyn induced programmed cell death strongly correlates 
with caspase-12 activity and was less dependent on the function of AIF. In fact, absence of 
caspase-12 prevented apoptosis and AIF translocation to the nucleus. Conversely, lack of AIF 
merely reduced the number of apoptotic cells. Furthermore, nuclear caspase-12 is found in 
every single AIF- apoptotic cell treated with tunicamycin. These data revealed a direct 
correlation of tunicamycin induced ER stress apoptosis with caspase-12 activation.  
We observed cell death in 3% of AIF- cells, even without stress agents. We could 
otherwise expect that lack of AIF, a mitochondrial protein with oxidoreductase activity 23, 
may influence the ability of cells to undergo apoptosis. On the contrary, apoptosis was 
detected in AIF- cell exposed to H2O2 excluding an increased resistance due to a difference in 
their bioenergetic condition. 
All together these data suggest that different apoptotic factors act as primus movens of 
the apoptotic cascades activated either by changes of Ca2+ homeostasis or protein misfolding. 
We also observed a reinforcing function of these two apoptotic factors between each other. 
We propose a model to describe these observations (Figure 7). In the presence of thapsigargin 
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the first change in the cell is the increase of intracellular Ca2+ concentration 1 (Figure 7A). 
This appears to have a stronger effect on the release and activation of AIF from the 
mitochondria. In fact, in the absence of AIF cells do not undergo apoptosis and there is a 
strict correlation of AIF translocation to the nucleus and activation of apoptosis in caspase-
12- cells. However, the percentage of cells activating AIF is reduced when caspase-12 is 
absent. This indicates that caspase-12 itself or a downstream factor can reinforce AIF 
activation in these detrimental conditions. Secondly, we observed that increased intracellular 
Ca2+ directly caused caspase-12 translocation inside AIF- nuclei. However, not all the cells 
activate caspase-12 suggesting that AIF itself acts as a positive signal for this activation. In 
addition, the effective block of cell death by calpain inhibitors suggested that calpains are 
probably the proteases controlling activation of both factors. Figure 7B shows a schematic 
representation of the cell treated with tunicamycin. Protein misfolding appears to have a 
direct role on caspase-12 activation and release from the ER. In fact a complete preservation 
from cell death and AIF activation was observed in caspase-12- cells. Furthermore, in this 
condition AIF activation appears to be dependent on caspase-12 or on an intermediate still 
unknown signal downstream of it. We suggest that calpains are probably involved also in 
protein misfolding activated cell death because calpain inhibitors can block apoptosis. Based 
on the observation that lack of AIF partially preserves cells from apoptosis, we suggest that 
caspase-12 is probably the first response to protein misfolding but to effectively initiate 
apoptosis it activates other effectors such as AIF. On the other hand, lack of AIF reduces but 
not prevents apoptosis reinforcing the hypothesis that this pathway is probably activated also 
by other effectors. We have not identified yet the factors involved in the cross talk of the two 
pathways. Calcium itself may play a role. It is also known that Bax and Bak can sense ER 
damage and function on mitochondrial membrane permeabilization 28.  
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Conclusions 
In summary, here we reported for the first time co-activation of AIF and caspase-12 as 
apoptotic responses to two ER stress conditions. The novel finding of this study is that 
changes in intracellular calcium activate AIF together with caspase-12 but AIF is necessary 
for this response. Interestingly, we showed caspase-12 translocation to the nucleus even in 
the absence of chromatin condensation. These data suggest that caspase-12 relocalization to 
the nucleus does not necessarily correlate with DNA fragmentation. On the other hand, AIF 
is not required for protein misfolding induced apoptosis while, in this case, caspase-12 has a 
primary function both on AIF activation and cell death. Therefore, we unraveled interactions 
of mitochondrial and ER apoptotic factors in ER stress induced cell demise. Future studies 
will be focusing on defining key players at the intersection of these different apoptotic 
pathways. 
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Legends to figure 
Figure 1. Co-activation of AIF and caspase-12 after thapsigargin and tunicamycin 
treatments. 
A-O: Fluorescent microscopy of NIH3T3 cells double stained with anti-AIF (A, D, G, J and 
M, green) and anti-caspase-12 antibodies (B, E, H, K and N, red). Cells were stressed with 
2µΜ thapsigargin (TG) for 48 hours, 2µg/ml tunicamycin (TM) for 48 hours, 400µM 
hydrogen peroxide (H2O2) for 12 hours, 1µM  MnCl2 (MnCl2) for 48 hours or not stressed 
(untr.). Merged images of AIF and caspase-12 staining are shown in C, F, I, L and O where 
DAPI staining labels nuclei in blue. Scale bar: 10 µm. Inserts are confocal images of the 
thapsigargin or tunicamycin treated NIH3T3 cells triple stained with anti-AIF (blue in D and 
G), anti-caspase-12 (red in E and H) and TUNEL (green in F and I). Merged confocal images 
are shown in F and I (inserts, MERGE). Co-localization of AIF, caspase-12 and TUNEL was 
confirmed by confocal microscopy (inserts).  
P: Statistical analysis of apoptosis (TUNEL positive nuclei, green bars) and nuclear 
translocation of AIF (blue bars) and caspase-12 (red bars). Values are shown as percentage of 
stained nuclei versus the number of total nuclei. 
Q: Western blot analysis of AIF and caspase-12 in nuclear enriched lysates purified from 
NIH3T3 cells either untreated (untr.) or treated with hydrogen peroxide (H2O2), 
 manganesium chloride (MnCl2), thapsigargin (TG) and tunicamycin (TM). The amounts of 
protein were normalized with western blotting of the nuclear protein marker acetyl-histone-3 
(H3). Contamination of the nuclear enriched lysates was checked with a mitochondrial 
protein marker (C5) and cytoskeleton marker actin. Last lane on the right (untr.) shows total 
cell lysates analyzed with the same antibodies. In total lysates of untreated cells the anti-
caspase-12 antibody detects the uncleaved 57kD protein. 
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R: Western blot analysis of activated caspase-3 and caspase-9 in total protein lysates purified 
from untreated (untr.) and treated NIH3T3 cells. The amounts of protein were normalized 
with the nuclear protein marker acetyl-histone-3 (H3).  
 
Figure 2. Changes in intracellular calcium and activation of protein misfolding response 
after thapsigargin and tunicamycin treatments 
A: Analysis of intracellular calcium in either untreated (untr.) NIH3T3 cells or treated with 
2µM thapsigargin (black bars) or 2µg/ml tunicamycin (white bars) for 6, 12, 24 and 48 hours. 
Fluorescence intensity was reported as the mean amplitude of 20 different transversal layers 
of 20 cells. 
B: RT-PCR expression analysis of two protein misfolding sensor genes: CHOP/Gadd153 and 
GRP78/Bip. NIH3T3 cells were treated with 2µΜ thapsigargin (TG) and 2µg/ml tunicamycin 
(TM) for 12, 24 and 48 hours. RT-PCR was normalized with GAPDH.  
C-K: confocal microscopy of NIH3T3 cells either untreated (untr.) or treated with 2µM 
thapsigargin (TG) or 2µg/ml tunicamycin (TM) for 48 hours and double stained with 
antibodies anti-mitochondrial marker cytochrome c (CYT-C, red in C, F and I) and anti-AIF 
(AIF, green in D, G and J).  Merged images are shown in E, H and K.  
L-T: confocal microscopy of NIH3T3 cells either untreated (untr.) or treated with 2µM 
thapsigargin (TG) or 2µg/ml tunicamycin (TM) for 48 hours and double stained with 
antibodies anti-ER marker ERAB (red in L, O and R) and anti-caspase-12 (casp-12, green in 
M, P and S).  Merged images are shown in N, Q and T.  
 
Figure 3. Translocations of AIF and caspase-12 are blocked by calpain-inhibitors. 
A: Statistical analysis of cell death of NIH3T3 cells pre-treated with either pan-caspase 
inhibitor (zvad, 50µM) or with calpain-inibitors I (alln, 25µM), II (allm, 5µM), calpain-
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inibitors I and II (alln-allm) or calpastatin (castn, 20µM) and then exposed to either 2µΜ 
thapsigargin (TG) or 2µg/ml tunicamycin (TM) for 48 hours or 400µM H2O2 for 12 hours. 
Percentages of cell death (%) were calculated as number of TUNEL-positive nuclei versus 
total number of nuclei. 
B: Western blot analysis of AIF and caspase-12 on nuclear enriched lysates purified from 
NIH3T3 cells either untreated (untr.) or treated with thapsigargin (TG) or tunicamycin (TM) 
in the presence of pan-caspase-inhibitor (casp.inh) or calpain-inhibitors I and II (calp.inh) or 
calpastatin (castn). The amounts of protein were normalized with the nuclear protein marker 
acetyl-histone-3 (H3).  
C-N: Confocal microscopy of thapsigargin treated NIH3T3 cells in the absence (C-E) or 
presence of caspase inhibitor (F-H) or calpain-inhibitors (I-K) or calapstatin peptide (L-N) 
shows that calpain-inhibitors and calpastatin prevent AIF and caspase-12 translocation to the 
nucleus (arrows).  
O-Z: Confocal microscopy of tunicamycin treated NIH3T3 cells in the absence (O-Q) or 
presence of caspase inhibitor (R-T) or calpain-inhibitors (U-W) or calapstatin peptide (X-Z) 
shows that calpain-inhibitors and calpastatin prevent AIF and caspase-12 translocation to the 
nucleus (arrows). 
 
Figure 4. Characterization of AIF- and caspase-12- stable NIH3T3 clones  
A-E: Immunofluorescence with AIF antibody on wild type (non transf.), control RNAi (contr. 
AIF) and stable AIF knock-down RNAi clones (#1, #2, #3). Scale bar: 10 µm. 
F-J: Immunofluorescence with caspase-12 antibody on wild type (non transf.), control RNAi  
(contr. Casp-12) and stable caspase-12 knock-down RNAi clones (#1, #4, #6).  
Cells were photographed with the same exposure time (1000 ms).  
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K: Western blot analysis of AIF and caspase-12 expression on protein lysates purified from 
AIF- stable clones #1, #2 and #3 and caspase12- stable clones #1, #4 and #6. In the first lane 
protein lysates from control wild type cells (non transf.) and in the second lane control 
shRNAs were analyzed (contr. AIF and contr. Casp-12). The amount of protein was 
normalized with the β-tubulin antibody. 
 
Figure 5. Analysis of caspase-12 translocation in AIF- stable clones. 
A: Statistical analysis of apoptisis (TUNEL positive, blue bars for control RNAi and green 
bars for AIF- RNAi) and caspase-12 nuclear translocation (red bars) in stable clones obtained 
with AIF specific shRNA (green and red bars) and AIF control shRNA (blue bars).  
B: Western blotting of AIF and caspase-12 in nuclear enriched lysates from stable clones 
obtained with AIF control shRNA (contr.) and with AIF specific shRNA. Clones were either 
untreated (untr.) or treated with 2µM thapsigargin for 48 hours in the absence or presence of 
calpain inhibitors (calp. inh.) and calpastatin (castn). Western blotting was normalized by 
analysis of nuclear acetyl-histone-3 (H3). 
C-N: Immunofluorescence of AIF- stable clone #1 treated with 2µM  thapsigargin (TG) in the 
absence or presence of calpain inhibitors (calp. inh.) and calpastatin peptide (castn) and 
double stained with TUNEL (C, F, I and L) and caspase-12 antibody (D, G, J and M). 
Merged images with DAPI are shown in E, H, K, N. Arrow in H shows a TUNEL-negative 
cell with nuclear localization of caspase-12. 
O-Z: Immunofluorescence of AIF- stable clone #1 treated with 2µg/ml tunicamycin (TM) in 
the absence or presence of calpain inhibitors (calp. inh.) and calpastatin (castn) and double 
stained with TUNEL (O, R, U and X) and caspase-12 antibody (P, S, V and Y). Merged 
images with DAPI are shown in Q, T, W, Z.  
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Figure 6. Analysis of AIF translocation in caspase-12- stable clones. 
A: Statistical analysis of apoptotic cells (TUNEL positive, blue bars for control RNAi and 
green bars for caspase-12- RNAi) and AIF nuclear translocation (red bars) in stable clones 
obtained with caspase-12 specific shRNA (green and red bars) and caspase-12 control 
shRNA (blue bars).  
B: Western blotting of AIF and caspase-12 in nuclear enriched lysates from stable clones 
obtained with caspase-12 control shRNA (contr.) and with caspase-12 specific shRNA. 
Clones were either untreated (untr.) or treated with thapsigargin (TG) or tunicamycin (TM) in 
the absence or presence of calpain inhibitors (calp. inh.) and calpastatin peptide (castn). 
Western blotting was normalized by analysis of nuclear acetyl-histone-3 (H3). 
C-N Immunofluorescence of caspase-12- stable clone #1 treated with 2µM thapsigargin (TG) 
for 48 hours in the absence or presence of calpain inhibitors (calp. inh.) and calpastatin 
peptide (castn) and double stained with TUNEL (C, F, I and L) and AIF antibody (D, G, J 
and M). Merged images with DAPI are shown in E, H, K, N. Arrow in H shows a TUNEL-
positive cell with nuclear localization of AIF. 
O-Z Immunofluorescence of caspase-12- stable clone #1 treated with 2µg/ml tunicamycin 
(TM) for 48 hours in the absence or presence of calpain inhibitors (calp. inh.) and calpastatin 
peptide (castn) and double stained with TUNEL (O, R, U and X) and AIF antibody (P, S, V 
and Y). Merged images with DAPI are shown in Q, T, W, Z.  
 
Figure 7. Interaction between AIF and caspase-12 apoptotic pathways. 
A: Thapsigargin treatment inhibits ER-associated Ca2+-ATPase and increases intracellular 
Ca2+. AIF has a prevalent role on the cell death program (thick arrow) but caspase-12 either 
directly or indirectly positively reinforces this pathway (dashed arrows).  
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B: Caspase-12 is necessary for the apoptotic process together with AIF activation in response 
to protein misfolding (thick arrow). AIF activation downstream to caspase-12 can be either a 
direct or indirect response (dashed arrows).  
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Table 1. Statistical analysis on AIF- and caspase 12- clones after thapsigargin and 
tunicamycin treatments 
 
  
treatment 
 
apoptotic 
AIF- 
 
AIF- / 
nuclear caspase 
12 
apoptotic 
caspase 12- 
caspase 12- / 
nuclear AIF 
wt 
untreated 3 0 0 0 0 
zvad 3 0 - - - 
alln allm 3 0 - - - 
TG 3 24 30 30 98 
TG zvad 3 24 30 30 98 
TG alln 3 15 3 3 10 
TG allm 3 0 6 6 40 
TG alln allm 3 0 2 2 1 
TG castn 3 0 0 0 0 
TM 20 20 0 0 50 
TM zvad 20 20 0 0 50 
TM alln 14 14 0 0 30 
TM allm 3 2 0 0 7 
TM alln allm 3 0 0 0 0 
TG castn 3 0 0 0 0 
H2O2 99 0 97 97 98 
MnCl2 91 91 1 0 92  
All the values are represented as the percentage of TUNEL positive cells versus total number of the cells. Mean 
values have been calculated by three counts of three different experiments.  
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